{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:49:12Z","timestamp":1790603352453,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.arth.2017.08.039","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T23:15:17Z","timestamp":1504566917000},"page":"533-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty"],"prefix":"10.1016","volume":"33","author":[{"given":"Jonathan H.","family":"Garfinkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Gladnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niama","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Romness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2017.08.039_bib1","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2017.08.039_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and economic burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib3","article-title":"Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty: evidence-based guideline and evidence report","year":"2011","journal-title":"J\u00a0Am Acad Ortho Surg"},{"key":"10.1016\/j.arth.2017.08.039_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/jth.13566","article-title":"Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis","volume":"15","author":"Kapoor","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.arth.2017.08.039_bib5","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a systematic review and meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00590-012-0987-y","article-title":"Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing","volume":"23","author":"Sindali","year":"2013","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1016\/j.arth.2017.08.039_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1302\/0301-620X.93B1.24987","article-title":"Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study","volume":"93","author":"Jensen","year":"2011","journal-title":"J\u00a0Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2017.08.039_bib8","first-page":"170","article-title":"Retrospective evaluation of postoperative adverse drug events in patients receiving rivaroxaban following major orthopedic surgery compared to standard therapy in a community hospital","volume":"1","author":"Cieri","year":"2016","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.arth.2017.08.039_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.arth.2015.12.007","article-title":"The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty","volume":"31","author":"Nam","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.arth.2016.01.065","article-title":"Risk-stratified venous thromboembolism prophylaxis after total joint arthroplasty: aspirin and sequential pneumatic compression devices vs aggressive chemoprophylaxis","volume":"31","author":"Odeh","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib11","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib12","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2017.08.039_bib13","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2017.08.039_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.arth.2015.12.027","article-title":"Rivaroxaban use for thrombosis prophylaxis is associated with early periprosthetic joint infection","volume":"31","author":"Brimmo","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2017.08.039_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MBC.0000000000000121","article-title":"Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty","volume":"25","author":"Zou","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.arth.2017.08.039_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.arth.2016.02.080","article-title":"Development and validation of a risk stratification system for pulmonary embolism after elective primary total joint arthroplasty","volume":"31","author":"Bohl","year":"2016","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317307623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540317307623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:21:38Z","timestamp":1563531698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540317307623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0883540317307623"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2017.08.039","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Incidence of Bleeding and Wound Complications With Factor-Xa Inhibitors After Total Joint Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2017.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}